These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12467566)

  • 1. RORalpha: an orphan nuclear receptor on a high-cholesterol diet.
    Willson TM
    Structure; 2002 Dec; 10(12):1605-6. PubMed ID: 12467566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha.
    Kallen JA; Schlaeppi JM; Bitsch F; Geisse S; Geiser M; Delhon I; Fournier B
    Structure; 2002 Dec; 10(12):1697-707. PubMed ID: 12467577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of the human RORalpha Ligand binding domain in complex with cholesterol sulfate at 2.2 A.
    Kallen J; Schlaeppi JM; Bitsch F; Delhon I; Fournier B
    J Biol Chem; 2004 Apr; 279(14):14033-8. PubMed ID: 14722075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of natural ligands of retinoic acid receptor-related orphan receptor alpha ligand-binding domain expressed in Sf9 cells--a mass spectrometry approach.
    Bitsch F; Aichholz R; Kallen J; Geisse S; Fournier B; Schlaeppi JM
    Anal Biochem; 2003 Dec; 323(1):139-49. PubMed ID: 14622968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the retinoid orphan-related receptor-alpha coactivator binding interface: a structural basis for ligand-independent transcription.
    Harris JM; Lau P; Chen SL; Muscat GE
    Mol Endocrinol; 2002 May; 16(5):998-1012. PubMed ID: 11981035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition from monomeric to homodimeric DNA binding by nuclear receptors: identification of RevErbAalpha determinants required for RORalpha homodimer complex formation.
    Moraitis AN; Giguère V
    Mol Endocrinol; 1999 Mar; 13(3):431-9. PubMed ID: 10077000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of orphan receptor-mediated transcription by Ca(2+)/calmodulin-dependent protein kinase IV.
    Kane CD; Means AR
    EMBO J; 2000 Feb; 19(4):691-701. PubMed ID: 10675338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coactivators for the orphan nuclear receptor RORalpha.
    Atkins GB; Hu X; Guenther MG; Rachez C; Freedman LP; Lazar MA
    Mol Endocrinol; 1999 Sep; 13(9):1550-7. PubMed ID: 10478845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The co-repressor hairless protects RORalpha orphan nuclear receptor from proteasome-mediated degradation.
    Moraitis AN; Giguère V
    J Biol Chem; 2003 Dec; 278(52):52511-8. PubMed ID: 14570920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of oxysterol 7alpha-hydroxylase (Cyp7b1) as a novel retinoid-related orphan receptor alpha (RORalpha) (NR1F1) target gene and a functional cross-talk between RORalpha and liver X receptor (NR1H3).
    Wada T; Kang HS; Angers M; Gong H; Bhatia S; Khadem S; Ren S; Ellis E; Strom SC; Jetten AM; Xie W
    Mol Pharmacol; 2008 Mar; 73(3):891-9. PubMed ID: 18055760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid receptor-related orphan receptor alpha as a therapeutic target in the treatment of dyslipidemia and atherosclerosis.
    Jakel H; Fruchart-Najib J; Fruchart JC
    Drug News Perspect; 2006 Mar; 19(2):91-7. PubMed ID: 16628264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The "CholesteROR" protective pathway in the vascular system.
    Boukhtouche F; Mariani J; Tedgui A
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):637-43. PubMed ID: 14751813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of orphan nuclear receptors in the development and function of the immune system.
    Dzhagalov I; Zhang N; He YW
    Cell Mol Immunol; 2004 Dec; 1(6):401-7. PubMed ID: 16293208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The orphan nuclear receptor RORalpha regulates circadian transcription of the mammalian core-clock Bmal1.
    Akashi M; Takumi T
    Nat Struct Mol Biol; 2005 May; 12(5):441-8. PubMed ID: 15821743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional activation of HIF-1 by RORalpha and its role in hypoxia signaling.
    Kim EJ; Yoo YG; Yang WK; Lim YS; Na TY; Lee IK; Lee MO
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1796-802. PubMed ID: 18658046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the orphan nuclear receptor RORalpha induces growth arrest in androgen-independent DU 145 prostate cancer cells.
    Moretti RM; Marelli MM; Motta M; Polizzi D; Monestiroli S; Pratesi G; Limonta P
    Prostate; 2001 Mar; 46(4):327-35. PubMed ID: 11241556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activation and repression by RORalpha, an orphan nuclear receptor required for cerebellar development.
    Harding HP; Atkins GB; Jaffe AB; Seo WJ; Lazar MA
    Mol Endocrinol; 1997 Oct; 11(11):1737-46. PubMed ID: 9328355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A second class of nuclear receptors for oxysterols: Regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol).
    Wang Y; Kumar N; Crumbley C; Griffin PR; Burris TP
    Biochim Biophys Acta; 2010 Aug; 1801(8):917-23. PubMed ID: 20211758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gene encoding fibrinogen-beta is a target for retinoic acid receptor-related orphan receptor alpha.
    Chauvet C; Bois-Joyeux B; Fontaine C; Gervois P; Bernard MA; Staels B; Danan JL
    Mol Endocrinol; 2005 Oct; 19(10):2517-26. PubMed ID: 15941850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMOylation of RORalpha potentiates transcriptional activation function.
    Hwang EJ; Lee JM; Jeong J; Park JH; Yang Y; Lim JS; Kim JH; Baek SH; Kim KI
    Biochem Biophys Res Commun; 2009 Jan; 378(3):513-7. PubMed ID: 19041634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.